Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases

Journal of Rheumatology

Volumn 41, Issue 4, 2014, Pages 792-798

  Saketkoo, Lesley Ann ^a   Mittoo, Shikha ^b   Frankel, Sid ^c   LeSage, Daphne ^d   Sarver, Catherine ^e   Phillips, Kristine ^e   Strand, Vibeke ^f   Matteson, Eric L ^g  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Louisiana Office of Public Health   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f STANFORD UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

Author keywords

Connective tissue disease; Interstitial lung disease; Outcome and process assessment; Patient perspective; Rheumatoid arthritis; Systemic sclerosis

Indexed keywords

CLINICAL FEATURE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; COUGHING; DISEASE ACTIVITY; DISEASE SEVERITY; DYSPNEA; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; CONNECTIVE TISSUE DISEASES; CONSENSUS DEVELOPMENT; DELPHI STUDY; DISEASE MANAGEMENT; HEALTH CARE PERSONNEL; INFORMATION PROCESSING; INTERDISCIPLINARY COMMUNICATION; LUNG DISEASES, INTERSTITIAL; MALE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

CONNECTIVE TISSUE DISEASES; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DELPHI TECHNIQUE; DISEASE MANAGEMENT; FOCUS GROUPS; HEALTH PERSONNEL; HUMANS; INTERDISCIPLINARY COMMUNICATION; LUNG DISEASES, INTERSTITIAL; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84897447766     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131251     Document Type: Review

References (7)

1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
2. Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
3. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 2011;183:372-8.
4. Komocsi A, Vorobcsuk A, Faludi R, Pintér T, Lenkey Z, Költo G, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 2012;51:1027-36.
5. Saketkoo LA, Matteson EL, Brown KK, Seibold JR, Strand V. Developing disease activity and response criteria in connective tissue disease related interstitial lung disease. J Rheumatol 2011;38:1514-8.
6. Swigris JJ, Stewert AL, Gould MK, Wilson SR. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005;3:61.
7. Boers M, Brooks P, Strand V, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.